The FDA (Food and Drug Administration) “stands accused of being little more than a rubber-stamping agency for Big Pharma.” “The FDA has progressively morphed into a mere pawn and instrument of the drug industry, which has little to do with drug safety, and everything to do with maximizing profits.” writes Dr. Mercola in an article, [...]
Ranbaxy Allocates $500 Million to Resolve Compliance Dispute
December 21, 2011 By
Japanese drug maker, Daiichi Sankyo, announced that its Indian unit, pharmaceutical giant, Ranbaxy Laboratories, Ltd., had reached an agreement with the U.S. Food and Drug Administration regarding its manufacturing practices. The company’s settlement with the FDA outlines its intent to improve procedures and policies in its production facilities in order to ensure data integrity and [...]